Literature DB >> 25475704

Taming of the beast: shaping Myc-dependent amplification.

Elmar Wolf1, Charles Y Lin2, Martin Eilers3, David L Levens4.   

Abstract

Myc deregulation is a hallmark oncogenic event where overexpression of the transcription factor gives rise to numerous tumorigenic phenotypes. The complex consequences of Myc deregulation have prevented clear mechanistic interpretations of its function. A synthesis of recent experimental observations offers a consensus on the direct transcriptional function of Myc: when overexpressed, Myc broadly engages the established euchromatic cis-regulatory landscape of the cell, where the factor generally amplifies transcription. The level of Myc binding at target genes and the transcriptional output are differentially modulated by additional regulators, including Miz1. Targeting Myc oncogenic activity will require an understanding of whether amplification promotes tumorigenesis and the consequences of amplification in tumors adapted to oncogenic Myc.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Myc; cancer; transcription

Mesh:

Substances:

Year:  2014        PMID: 25475704      PMCID: PMC4380620          DOI: 10.1016/j.tcb.2014.10.006

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  64 in total

1.  c-Myc regulates transcriptional pause release.

Authors:  Peter B Rahl; Charles Y Lin; Amy C Seila; Ryan A Flynn; Scott McCuine; Christopher B Burge; Phillip A Sharp; Richard A Young
Journal:  Cell       Date:  2010-04-30       Impact factor: 41.582

2.  c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

Authors:  Zuqin Nie; Gangqing Hu; Gang Wei; Kairong Cui; Arito Yamane; Wolfgang Resch; Ruoning Wang; Douglas R Green; Lino Tessarollo; Rafael Casellas; Keji Zhao; David Levens
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

3.  Transcriptional amplification in tumor cells with elevated c-Myc.

Authors:  Charles Y Lin; Jakob Lovén; Peter B Rahl; Ronald M Paranal; Christopher B Burge; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

4.  Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress.

Authors:  Kishore B Challagundla; Xiao-Xin Sun; Xiaoli Zhang; Tiffany DeVine; Qinghong Zhang; Rosalie C Sears; Mu-Shui Dai
Journal:  Mol Cell Biol       Date:  2011-08-01       Impact factor: 4.272

Review 5.  MYC on the path to cancer.

Authors:  Chi V Dang
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

6.  The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis.

Authors:  Barbara Herkert; Anne Dwertmann; Steffi Herold; Mona Abed; Jean-Francois Naud; Florian Finkernagel; Gregory S Harms; Amir Orian; Michael Wanzel; Martin Eilers
Journal:  J Cell Biol       Date:  2010-03-22       Impact factor: 10.539

7.  Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice.

Authors:  Laura Soucek; Jonathan R Whitfield; Nicole M Sodir; Daniel Massó-Vallés; Erika Serrano; Anthony N Karnezis; Lamorna Brown Swigart; Gerard I Evan
Journal:  Genes Dev       Date:  2013-03-01       Impact factor: 11.361

Review 8.  Revisiting global gene expression analysis.

Authors:  Jakob Lovén; David A Orlando; Alla A Sigova; Charles Y Lin; Peter B Rahl; Christopher B Burge; David L Levens; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2012-10-26       Impact factor: 41.582

9.  MYC acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase.

Authors:  Mandeep Kaur; Michael D Cole
Journal:  Cancer Res       Date:  2012-11-07       Impact factor: 12.701

10.  Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis.

Authors:  Chen-Ju Lin; Zeina Nasr; Prem K Premsrirut; John A Porco; Yoshitaka Hippo; Scott W Lowe; Jerry Pelletier
Journal:  Cell Rep       Date:  2012-04-19       Impact factor: 9.423

View more
  69 in total

Review 1.  MYC: connecting selective transcriptional control to global RNA production.

Authors:  Theresia R Kress; Arianna Sabò; Bruno Amati
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

2.  Co-occurrence of MYC amplification and TP53 mutations in human cancer.

Authors:  Peter Ulz; Ellen Heitzer; Michael R Speicher
Journal:  Nat Genet       Date:  2016-02       Impact factor: 38.330

Review 3.  MYC and metabolism on the path to cancer.

Authors:  Annie L Hsieh; Zandra E Walton; Brian J Altman; Zachary E Stine; Chi V Dang
Journal:  Semin Cell Dev Biol       Date:  2015-08-12       Impact factor: 7.727

4.  The MYC mRNA 3'-UTR couples RNA polymerase II function to glutamine and ribonucleotide levels.

Authors:  Francesca R Dejure; Nadine Royla; Steffi Herold; Jacqueline Kalb; Susanne Walz; Carsten P Ade; Guido Mastrobuoni; Jens T Vanselow; Andreas Schlosser; Elmar Wolf; Stefan Kempa; Martin Eilers
Journal:  EMBO J       Date:  2017-04-13       Impact factor: 11.598

5.  MYC Targeted Long Noncoding RNA DANCR Promotes Cancer in Part by Reducing p21 Levels.

Authors:  Yunqi Lu; Zhongyi Hu; Lingegowda S Mangala; Zachary E Stine; Xiaowen Hu; Dahai Jiang; Yan Xiang; Youyou Zhang; Sunila Pradeep; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Angelo M DeMarzo; Anil K Sood; Lin Zhang; Chi V Dang
Journal:  Cancer Res       Date:  2017-11-27       Impact factor: 12.701

6.  c-MYC mRNA tail tale about glutamine control of transcription.

Authors:  Chi V Dang
Journal:  EMBO J       Date:  2017-05-15       Impact factor: 11.598

7.  MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells.

Authors:  Brian J Altman; Annie L Hsieh; Arjun Sengupta; Saikumari Y Krishnanaiah; Zachary E Stine; Zandra E Walton; Arvin M Gouw; Anand Venkataraman; Bo Li; Pankuri Goraksha-Hicks; Sharon J Diskin; David I Bellovin; M Celeste Simon; Jeffrey C Rathmell; Mitchell A Lazar; John M Maris; Dean W Felsher; John B Hogenesch; Aalim M Weljie; Chi V Dang
Journal:  Cell Metab       Date:  2015-09-17       Impact factor: 27.287

Review 8.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

9.  Loss of Nmp4 optimizes osteogenic metabolism and secretion to enhance bone quality.

Authors:  Yu Shao; Emily Wichern; Paul J Childress; Michele Adaway; Jagannath Misra; Angela Klunk; David B Burr; Ronald C Wek; Amber L Mosley; Yunlong Liu; Alexander G Robling; Nickolay Brustovetsky; James Hamilton; Kylie Jacobs; Deepak Vashishth; Keith R Stayrook; Matthew R Allen; Joseph M Wallace; Joseph P Bidwell
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-01-15       Impact factor: 4.310

Review 10.  The dynamic control of signal transduction networks in cancer cells.

Authors:  Walter Kolch; Melinda Halasz; Marina Granovskaya; Boris N Kholodenko
Journal:  Nat Rev Cancer       Date:  2015-08-20       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.